Pure Global

“Seawon” Claudicare Percutaneous Endoscopic Neurolysis and Foraminoplasty System - Taiwan Registration a28dc25452477a1257a6f2e5eeef1670

Access comprehensive regulatory information for “Seawon” Claudicare Percutaneous Endoscopic Neurolysis and Foraminoplasty System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a28dc25452477a1257a6f2e5eeef1670 and manufactured by Seawon Meditech Co., Ltd.. The authorized representative in Taiwan is BUTICON INTERNATIONAL CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
a28dc25452477a1257a6f2e5eeef1670
Registration Details
Taiwan FDA Registration: a28dc25452477a1257a6f2e5eeef1670
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Seawon” Claudicare Percutaneous Endoscopic Neurolysis and Foraminoplasty System
TW: “希旺”克勞蒂椎間孔成形術器具組
Risk Class 2
MD

Registration Details

a28dc25452477a1257a6f2e5eeef1670

Ministry of Health Medical Device Import No. 031300

DHA05603130001

Company Information

Korea, Republic of

Product Details

For details, it is Chinese approved copy of the imitation order

N Orthopedic devices

N1100 Arthroscopy

Imported from abroad

Dates and Status

Jul 17, 2018

Jul 17, 2028